ACADIA Pharmaceuticals Inc (ACAD)
Return on assets (ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 226,451 | -61,286 | -215,975 | -167,870 | -281,584 |
| Total assets | US$ in thousands | 1,187,760 | 748,956 | 587,812 | 700,122 | 782,616 |
| ROA | 19.07% | -8.18% | -36.74% | -23.98% | -35.98% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $226,451K ÷ $1,187,760K
= 19.07%
ACADIA Pharmaceuticals Inc's return on assets (ROA) varied significantly over the analyzed period. The ROA was consistently negative from December 31, 2020, to December 31, 2023, indicating that the company was not generating a sufficient return on its assets during these years. However, there was a notable improvement in ROA by December 31, 2024, reaching a positive 19.07%.
The substantial improvement in ROA in 2024 suggests that ACADIA Pharmaceuticals Inc may have undertaken strategic measures to enhance its operational efficiency and profitability. The positive ROA indicates that the company is utilizing its assets more effectively to generate profits, which could be a positive sign for investors and stakeholders.
Overall, the fluctuation in ACADIA Pharmaceuticals Inc's ROA highlights the importance of monitoring financial performance metrics like ROA to assess the company's ability to generate returns from its assets and to make informed investment decisions. Additional analysis would be beneficial to understand the factors driving these changes in ROA over time.
Peer comparison
Dec 31, 2024